What Glen Research Corp. does

Glen Research Corp. is a privately held specialty reagent manufacturer founded in 1986 and headquartered in Sterling, Virginia, operating as a subsidiary of Maravai LifeSciences (NASDAQ: MRVI). The company supplies the building blocks, supports, ancillary reagents, purification products, and modification/labeling chemistries used by research laboratories, pharmaceutical developers, and molecular diagnostics companies to perform DNA and RNA oligonucleotide synthesis on commercial synthesizers. Its core technology is grounded in phosphoramidite chemistry and includes both natural and modified nucleoside phosphoramidites, a portfolio of universal and specialty solid supports (including patented Universal Support III and Ionis-licensed Glen UnySupport), and ancillary reagents covering every step of the synthesis cycle — activation, capping, oxidation, sulfurization, detritylation, and UltraMild deprotection — as well as Glen-Pak reverse phase and Glen Gel-Pak desalting purification products.

The Sterling Quality and Sterling Performance programs are central to Glen Research's competitive positioning: every batch undergoes purity and identity testing, titration analysis, and synthesis testing, with Certificates of Analysis and HPLC traces provided to customers. Quantified performance claims include greater than 96% phosphorothioate linkage efficiency with Sulfurizing Reagent II and typically greater than 95% oligonucleotide yield with Universal Support III. The company also offers trimer phosphoramidites for codon-based mutagenesis, Oligo-Affinity Supports for purification of oligonucleotides and DNA-binding proteins, and a click chemistry platform for conjugate labeling.

Glen Research generates revenue primarily through one-time direct sales of reagents and supports via its own e-commerce storefront at glenresearch.com, supplemented by an international distributor network for global reach and a quote-based pricing model for commercial accounts. Customer segmentation is horizontal across academic research labs, biotech and pharma developers of oligonucleotide therapeutics (siRNA, antisense, aptamers), and molecular diagnostics companies. Marketing relies on The Glen Report newsletter, LinkedIn, technical content resources, and a product catalog organized around the complete oligonucleotide synthesis workflow. Recent product introductions — notably Tri-GalNAc CPG for hepatocyte-targeted therapeutics, Spacer Phosphoramidite C6, and a 1.0 M triethylammonium acetate buffer — indicate continued investment in product expansion aligned with therapeutic oligonucleotide market growth.

Name

Glen Research Corp.

Legal name

Glen Research Corp.

Website

https://glenresearch.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

Glen Research Corp. is a Sterling, Virginia-based subsidiary of Maravai LifeSciences that manufactures and sells phosphoramidites, supports, ancillary reagents, and purification products used in DNA and RNA oligonucleotide synthesis for academic research labs, pharmaceutical developers, and molecular diagnostics companies.

Ownership category

akta.pro rank

Headquarters

HQ city

Sterling

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Oligonucleotide Synthesis Reagents and Supports Sales: Revenue generated from the sale of DNA and RNA phosphoramidites, supports, ancillary reagents, purification supplies, and modification/labeling products to research institutions, pharmaceutical companies, and biotechnology firms. Products are sold directly via e-commerce and through international distributors.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Glen Research Corp. manufactures and sells high-purity reagents and supports used in the chemical synthesis of DNA and RNA oligonucleotides. Its portfolio includes phosphoramidite building blocks, ancillary synthesis reagents (activators, capping, oxidation, sulfurizing, deblocking, diluents), universal and specialized supports, oligonucleotide purification products, and modification/labeling chemistries, supplied to research laboratories, pharmaceutical/biotech firms, and molecular diagnostics companies worldwide.

Product overview

Glen Research Corp. delivers a comprehensive portfolio of reagents and supplies for DNA and RNA oligonucleotide synthesis, serving researchers and diagnostic companies for nearly 40 years. The product ecosystem is organized around the core synthesis workflow: nucleoside phosphoramidites (DNA, RNA, and analogs) as building blocks; ancillary reagents (activators, capping reagents, oxidation and sulfurizing reagents, deblocking agents, diluents, and UltraMild variants) that enable each step of the synthesis cycle; universal and specialized supports (Glen UnySupport, Universal Support III, Polystyrene Supports, Oligo-Affinity Support) for various synthesis and purification needs; and purification products (Glen-Pak RP cartridges, Glen Gel-Pak desalting columns) for post-synthesis isolation. The portfolio also includes modification and labeling reagents (NHS esters, azides, click chemistry) for adding functional groups and fluorescent dyes to oligonucleotides. All products are produced under the company's Sterling Quality and Performance quality management system, with Certificates of Analysis and HPLC traces provided for every batch.

Differentiator

Problem solved

Functional benefit

Brands

• Glen UnySupport: Universal support for oligonucleotide synthesis based on conformationally preorganized molecule
• Glen-Pak
• Glen Gel-Pak
• Glen Report
• Sterling Quality
• Universal Support III
• Oligo-Affinity Support

Products and services

• Natural DNA Phosphoramidites and Supports Phosphoramidites and controlled pore glass (CPG) supports for DNA synthesis, including standard base protection, depurination-resistant bases, trimer phosphoramidites, and UltraMild options for synthesis on commercial oligonucleotide synthesizers.
• Natural RNA Phosphoramidites and Supports Phosphoramidites and supports for RNA synthesis including standard RNA, 2'-OMe-RNA, 2'-MOE RNA, and UltraMild options, with RNA supports for 3' modification.
• Nucleoside Analog Phosphoramidites DNA and RNA nucleoside analogs and sugar-modified nucleoside phosphoramidites for specialized oligonucleotide synthesis applications.
• Activators Chemical activators including Tetrazole, 5-Ethylthio-1H-Tetrazole (ETT), 4,5-Dicyanoimidazole (DCI), and 5-Benzylthio-1H-tetrazole (BTT) for oligonucleotide synthesis activation.
• Capping Reagents Reagents including Cap Mix A, Cap Mix B, UniCap Phosphoramidite, and phenoxyacetic anhydride solutions for capping unreacted 5'-hydroxyl groups during synthesis.
• Oxidation Reagents Oxidizers including iodine solutions in various solvent systems and CSO (10-camphorsulfinyl oxime) for converting phosphite triesters to phosphate triesters.
• Sulfurizing Reagents Reagents for preparing phosphorothioate linkages using CE phosphoramidite chemistry, including Sulfurizing Reagent II (DDTT) available in powder and solution forms.
• Deblocking (Detritylation) Reagents Acids including dichloroacetic acid (DCA) and trichloroacetic acid (TCA) in various solvents for removing DMT protecting groups during synthesis.
• Diluents and Wash Reagents Anhydrous acetonitrile, tetrahydrofuran solutions, and solvent mixtures for diluting reagents and washing synthesis columns.
• UltraMild Synthesis Reagents Alternative protecting scheme using phenoxyacetyl (Pac) protected dA, 4-isopropyl-phenoxyacetyl (iPr-Pac) protected dG, and acetyl protected dC for deprotection compatible with sensitive labels.
• Glen UnySupport Universal support based on a conformationally preorganized molecule (N-methyl version of UnyLinker) for high-throughput oligonucleotide synthesis, available in various pore sizes (500Å, 1000Å, 1400Å, 2000Å) and formats including High Load and PS versions.
• Universal Support III Universal support using (±)-3-Amino-1,2-propanediol linker with amide-assisted dephosphorylation under mildly basic conditions, achieving typically greater than 95% yield of product oligonucleotide; protected by US Patent No. 6,770,754 and European Patent No. 1404695.
• Polystyrene Supports Polystyrene supports in bulk or column formats for ABI 3900 and other synthesizers, including low-volume supports and modifier supports.
• Oligo-Affinity Support (OAS) Polystyrene-based affinity support compatible with automated synthesis for purification of oligonucleotides and DNA-binding proteins from biological fluids, using an adenosine residue attached through exocyclic amino group for complementary strand binding.
• Empty Synthesis Columns and Frits Empty columns and replacement frits for ABI, Expedite, and MerMade synthesizers, including TWIST columns with various porosity options.
• Glen-Pak™ Reverse Phase Oligonucleotide Purification Products Reverse phase purification products for oligonucleotide purification using DMT group binding to RP supports for separating full-length sequences from failure sequences.
• Glen Gel-Pak™ Desalting Columns Gel-based desalting columns for removing salts and small molecules from oligonucleotide solutions.
• Oligonucleotide Purification Reagents Reagents used during oligonucleotide purification workflows, including triethylammonium acetate buffer solutions.
• NHS Esters N-hydroxysuccinimide ester compounds for labeling oligonucleotides with various functional groups.
• Azides Azide compounds for copper-free click chemistry labeling of oligonucleotides.
• Click and Copper-free Click Chemistry Product Line Chemistry platform for conjugation of labeled oligonucleotides using click reactions including strain-promoted azide-alkyne cycloaddition (SPAAC).
• Backbone Modification Phosphoramidites and Supports Phosphoramidites and supports for backbone modification of oligonucleotides used in modified oligonucleotide synthesis.
• Modifier Phosphoramidites and Supports Phosphoramidites and supports carrying modifiers for adding functional groups to synthetic oligonucleotides.
• Label Phosphoramidites and Supports Phosphoramidites and supports carrying fluorescent dyes and other labeling groups for direct incorporation during oligonucleotide synthesis.
• Trimer Phosphoramidites Pre-formed trinucleotide phosphoramidites for codon-based mutagenesis enabling clonal libraries with increased amino acid sequence variance, available as individual trimers or pre-made mixes.
• Tri-GalNAc CPG Solid Support Solid support delivering the full trivalent GalNAc ligand as a single building block during synthesis for liver-targeted therapeutic oligonucleotides including siRNA and antisense oligonucleotides.
• Spacer Phosphoramidite C6 Six-carbon aliphatic chain spacer phosphoramidite offering practical balance between flexibility, length, and synthetic robustness, and may be added in multiple additions when a longer spacer is required.
• 1.0 M Triethylammonium Acetate for RP-HPLC Triethylammonium acetate buffer at 1.0 M concentration for RP-HPLC oligonucleotide purification, complementing the 2.0 M traditional offering.

Quantifiable outcome

• Greater than 96% of linkages being phosphorothioate when using Sulfurizing Reagent II
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Ionis PharmaceuticalscoreTechnology or IntegrationGlen Research licenses the UnyLinker technology from Ionis Pharmaceuticals for their Glen UnySupport product line. The N-methyl version (Glen UnySupport) is preferred for high throughput oligonucleotide synthesis since methylamine rather than aniline is formed on deprotection. The N-phenyl version (marketed as UnyLinker by Ionis) is available for large scale synthesis.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• TriLink BioTechnologies: TriLink manufactures oligonucleotides, mRNA, and modified nucleoside triphosphates, and is also a Maravai LifeSciences subsidiary. It overlaps with Glen Research in serving oligonucleotide therapeutic customers and shares the same parent platform.
• Integrated DNA Technologies (IDT): IDT is the most direct competitor to Glen Research, offering custom oligonucleotides and a broad catalog of phosphoramidites, supports, and modification reagents for DNA/RNA synthesis. Both serve research, therapeutic, and diagnostic customers with overlapping product lines.
• LGC Biosearch Technologies: Biosearch Technologies sells oligonucleotide synthesis reagents, probes, and fluorescent dyes used in qPCR and diagnostics, overlapping with Glen's labeling and modification portfolio and serving similar molecular diagnostics customers.
• ChemGenes Corporation: ChemGenes is a specialty manufacturer of phosphoramidites, nucleosides, and oligonucleotide synthesis reagents, directly competing with Glen in the core phosphoramidite and custom synthesis reagent market.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher offers a comprehensive portfolio of molecular biology reagents, including oligonucleotide synthesis chemistries and custom oligo services through its Life Sciences Solutions segment, competing with Glen at the broad-catalog level.
• MilliporeSigma (Sigma-Aldrich): MilliporeSigma is a broad life science reagent incumbent that sells oligonucleotide synthesis reagents and ancillary chemicals as part of a much larger catalog, competing with Glen on commoditized reagents and bundled supply contracts.
• Agilent Technologies: Agilent supplies genomics reagents, arrays, and oligonucleotide synthesis services used in diagnostics and research, overlapping with Glen's customer base and competing for nucleic acid chemistry spend.
• QIAGEN: QIAGEN provides molecular biology reagents and sample technologies for genomics and diagnostics, with overlapping customers and adjacent reagent categories to Glen's molecular diagnostics-focused products.

Regional players

• Eurofins Genomics: Eurofins Genomics is a European-headquartered provider of custom oligonucleotides and synthesis services, competing with Glen for oligo reagent and custom synthesis demand, particularly outside the US.

Emerging players

• Bioneer Corporation: Bioneer is an Asia-based oligonucleotide synthesis and molecular biology reagent supplier, overlapping with Glen in phosphoramidite-based reagents and competing for global research and therapeutic customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/glen-research

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Glen Research Corp.